Judge Matthew Kacsmaryk, a United States District Court Judge for the Northern District of Texas is expected to rule as early as Friday, February 10 to reverse the Food and Drug Administration’s (FDA) January 3rd chemical abortion deregulation. Eight of the largest online chemical abortionists have gone on record saying they have plans to pivot away from Mifepristone to the sole use of Misoprostol. The upshot of the online chemical abortion companies’ new protocol means they intend for women to expel live babies at potentially any time throughout the pregnancy. The complaint is brought by eight associations of physicians and medical practices on behalf of themselves and their patients, representing thousands of doctors and hundreds of thousands of women. Rev. Jim Harden, medical ethicist and the author of Ethical Theory and Pertinent Standards in Women’s Reproductive Health—the only book to ever be endorsed by the late Dr. Edmund D. Pellegrino, M.D., M.A.C.P., Former Chairman of the President’s Council on Bioethics—responds.
Q&A:
- What is the nature of the case being brought against the FDA by these eight associations of physicians and medical practices?
Answer: The complaint is brought by eight associations of physicians and medical practices on behalf of themselves and their patients, representing thousands of doctors and hundreds of thousands of women. The ruling, expected as early as February 10, could reverse the Food and Drug Administration’s (FDA) January 3rd chemical abortion deregulation.
- How is the abortion industry responding to the prospect of the FDA retracting approval on chemical abortion, now responsible for over half of all abortions?
Answer: Eight of the largest online chemical abortionists have gone on record saying they have plans to pivot away from Mifepristone to the sole use of Misoprostol. The upshot of the online chemical abortion companies’ new protocol means they intend for women to expel live babies at potentially any time throughout the pregnancy given that most if not all online abortion businesses do not confirm the pregnancy nor determine how far along a woman is in her pregnancy prior to illegally mailing her the drugs.
- What is chemical abortion and how is the abortion industry’s proposed new process different?
Answer: Chemical abortion is a two-drug regimen: Mifepristone is taken to block a mother’s natural progesterone in order to kill the baby, and Misoprostol is taken 24-48 hours later to induce uterine contractions, expelling the dead baby. Misoprostol is approved by the FDA as an ulcer medication, warning it should not be taken by pregnant women. The physician plaintiffs insist that research to identify the long-term reproductive toxicology for women and girls which the FDA is required by law to conduct has not been done.
- What is the risk of this new process?
Answer: There is ample documentation that when a healthy pregnancy is terminated via abortion, there are long-term side effects such as 44% increased risk of breast cancer and a 5X increased risk of suicide. Medical standard of care is created by medical professionals, not by unelected bureaucrats with a political agenda. The willingness on the part of the decision-makers at the FDA to ignore the existing data and refusal to follow the law to research the safety of chemical abortion demonstrates their lack of fitness for the task.
- The physicians and associations of physicians bringing the complaint claim to represent their patients, thousands of women. Why do they feel obligated to act on behalf of all patients in the U.S.?
Answer: From what is already known, these drugs pose an extreme threat to women and their preborn boys and girls. This lawsuit is about protecting women and girls. The FDA, under the legal purview of the Biden Administration, is sacrificing the health and wellbeing of women and girls to protect a profiteering, unethical abortion industry.
- Is it ethical for a doctor to administer chemical abortion at all?
Answer: No, in fact the original Hippocratic Oath, to which doctors were formerly required to swear before practicing medicine independently states, “…I will not give to a woman an abortive remedy.” This charge was included because abortion violates the core purpose of medicine, to heal and maintain the health of the patient.
- What do you expect the response of the abortion industry to be in the coming days and weeks?
Answer: The abortion industry is going to try this case in the court of public opinion (the media), claiming that any move to reverse the FDA’s deregulation of chemical abortion is driven solely by politics and fearmongering. Yet, the physicians bringing their case seek to ensure that all the risks and side effects are known and considered by the FDA and by women and girls, abused by a fraudulent abortion industry.
- Is the abortion industry already preparing for the FDA’s deregulation of chemical abortion to be overturned?
Answer: Even now this abortion industry is encouraging and directing women to procure illegal abortions and cover their online footprint, asking women to become complicit in breaking the law while putting their health at risk. Rev. Harden concludes, “The FDA is not caring for women. It’s caring for the abortion empire.”
Rev. Jim Harden, CompassCare CEO:
Rev. James R. Harden, M.Div. is the CEO of CompassCare Pregnancy Services and lives outside of Rochester, NY with his wife and ten children. Rev. Harden pioneered the first measurable and repeatable medical model in the pregnancy center movement, helping hundreds of centers nationwide become more effective at reaching more women and saving more babies from abortion. He has written extensively on medical ethics, executive leadership, and pro-life strategy. Recently CompassCare’s pro-life medical office in Buffalo, NY was firebombed.
Daniel Tomlinson, CompassCare Director of Community Relations:
Daniel Tomlinson is the Director of Community Relations at CompassCare, a Pregnancy Center based in Buffalo, New York. CompassCare’s pro-life medical office in Buffalo that was firebombed on June 7th and reopened a miraculous 52 days later. Having served at CompassCare for 12 years, Daniel is passionate about resourcing the mission of CompassCare and educating the community on the equal value of every person. He and his wife have four children and live outside of Rochester, NY.
CONTACT: Jerry McGlothlin at: geraldmcg@outlook.com or 919-437-0001.
